Ahren Innovation Capital focuses on transformational companies at the intersection of deep technology and deep science, with key domains including Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. Their strategy involves providing patient and active capital to exceptional founders and teams across all stages, from pre-seed to pre-IPO, to help them create or penetrate massive markets.
Portfolio
1
Fund Size
$253M
Top Stage
Series D
Last 12 Mo
0
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| Cambridge Epigenetix | Series D | $88M | Nov 2021 |
Top Co-Investors
Temasek Holdings1 shared
Third Point Ventures1 shared
GV (Google Ventures)1 shared
Science1 shared
Sequoia Capital1 shared
Last updated: 27 February 2026